"Doylestown Health Cardiology offers compassionate, responsive heart care using state-of-the-art technology, and provides patient education in a professional, attentive environment. Doylestown Health Cardiology includes experienced, board-certified physicians, nurse practitioners, physician assistants and professional staff who work as a team to meet the needs of each individual patient."

During the past decade, Doylestown Health Cardiology conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 9 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Doylestown Health Cardiology" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Amgen" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Doylestown Health Cardiology" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Doylestown Health Cardiology" are "Atrial Fibrillation" (3 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Doylestown Health Cardiology" in a lesser frequency.

Most popular intervention types in "Doylestown Health Cardiology" are "Drug" (9 trials), "Device" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Empagliflozin" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Aprocitentan 12.5 mg" (1 trials) and "Aprocitentan 25 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Doylestown Health Cardiology" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Doylestown Health Cardiology". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Doylestown Health Cardiology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Doylestown Health Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".